Rhumbline Advisers Sells 11,700 Shares of Cigna Group $CI

Rhumbline Advisers decreased its position in shares of Cigna Group (NYSE:CI) by 2.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 574,223 shares of the health services provider’s stock after selling 11,700 shares during the period. Rhumbline Advisers owned 0.22% of Cigna Group worth $189,827,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of CI. Valeo Financial Advisors LLC grew its holdings in shares of Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Nuveen LLC acquired a new stake in shares of Cigna Group during the first quarter worth approximately $727,905,000. Price T Rowe Associates Inc. MD raised its position in Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. GQG Partners LLC lifted its position in Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in shares of Cigna Group by 38.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after purchasing an additional 457,052 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other news, CEO David Cordani bought 4,134 shares of the stock in a transaction dated Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

CI has been the topic of several recent research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research note on Wednesday. Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. Robert W. Baird set a $372.00 price objective on Cigna Group in a report on Thursday, August 14th. Wolfe Research lowered their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $334.05.

Cigna Group Stock Up 3.2%

CI stock opened at $278.12 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $74.29 billion, a P/E ratio of 15.18, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The firm has a 50-day moving average price of $286.74 and a 200-day moving average price of $299.18.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the business earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s payout ratio is 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.